Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter N Jensen

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Virology|April 6, 2007
MEK1/2 inhibitors block basal and transforming growth factor 1beta1-stimulated JC virus multiplicationVeerasamy Ravichandran, Peter N Jensen, Eugene O Major
Journal of Neuroimmunology|October 7, 2004
Differential effects of interferon-gamma on the expression of cyclooxygenase-2 in high-grade human gliomas versus primary astrocytesNazila Janabi, Peter N Jensen, Eugene O Major
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 27, 2013
Multiplex qPCR assay for ultra sensitive detection of JCV DNA with simultaneous identification of genotypes that discriminates non-virulent from virulent variantsCaroline F Ryschkewitsch, Peter N Jensen, Eugene O Major
Annals of Neurology|September 7, 2010
JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumabCaroline F Ryschkewitsch, Peter N Jensen, Maria Chiara Monaco, et al.
Annals of Neurology|March 10, 2011
Reply: To PMID 21246607Eugene O Major, Caroline F Ryschkewitsch, Peter N Jensen, et al.
Journal of Virology|August 25, 2006
Interactions between c-Jun, nuclear factor 1, and JC virus promoter sequences: implications for viral tropismVeerasamy Ravichandran, Bruce F Sabath, Peter N Jensen, et al.
Journal of Virology|February 21, 2014
Lymphocyte gene expression and JC virus noncoding control region sequences are linked with the risk of progressive multifocal leukoencephalopathyLeslie J Marshall, Michael W Ferenczy, Elizabeth L Daley, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|September 21, 2013
Clonal immortalized human glial cell lines support varying levels of JC virus infection due to differences in cellular gene expressionMichael W Ferenczy, Kory R Johnson, Shannon M Steinberg, et al.
JAMA Neurology|March 26, 2014
JC virus in CD34+ and CD19+ cells in patients with multiple sclerosis treated with natalizumabElliot M Frohman, Maria Chiara Monaco, Gina Remington, et al.
Plos Pathogens|November 13, 2012
Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathyMolly R Perkins, Caroline Ryschkewitsch, Julia C Liebner, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Virology|April 6, 2007
MEK1/2 inhibitors block basal and transforming growth factor 1beta1-stimulated JC virus multiplicationVeerasamy Ravichandran, Peter N Jensen, Eugene O Major
Journal of Neuroimmunology|October 7, 2004
Differential effects of interferon-gamma on the expression of cyclooxygenase-2 in high-grade human gliomas versus primary astrocytesNazila Janabi, Peter N Jensen, Eugene O Major
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 27, 2013
Multiplex qPCR assay for ultra sensitive detection of JCV DNA with simultaneous identification of genotypes that discriminates non-virulent from virulent variantsCaroline F Ryschkewitsch, Peter N Jensen, Eugene O Major
Annals of Neurology|September 7, 2010
JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumabCaroline F Ryschkewitsch, Peter N Jensen, Maria Chiara Monaco, et al.
Annals of Neurology|March 10, 2011
Reply: To PMID 21246607Eugene O Major, Caroline F Ryschkewitsch, Peter N Jensen, et al.
Journal of Virology|August 25, 2006
Interactions between c-Jun, nuclear factor 1, and JC virus promoter sequences: implications for viral tropismVeerasamy Ravichandran, Bruce F Sabath, Peter N Jensen, et al.
Journal of Virology|February 21, 2014
Lymphocyte gene expression and JC virus noncoding control region sequences are linked with the risk of progressive multifocal leukoencephalopathyLeslie J Marshall, Michael W Ferenczy, Elizabeth L Daley, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|September 21, 2013
Clonal immortalized human glial cell lines support varying levels of JC virus infection due to differences in cellular gene expressionMichael W Ferenczy, Kory R Johnson, Shannon M Steinberg, et al.
JAMA Neurology|March 26, 2014
JC virus in CD34+ and CD19+ cells in patients with multiple sclerosis treated with natalizumabElliot M Frohman, Maria Chiara Monaco, Gina Remington, et al.
Plos Pathogens|November 13, 2012
Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathyMolly R Perkins, Caroline Ryschkewitsch, Julia C Liebner, et al.
Pageof 1